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Satohiro Matsumoto*, Shunsuke Urayoshi and Yukio YoshidaAbstract
Background: Familial Mediterranean fever is a hereditary autoinflammatory disease, mainly characterized by
periodic fever and serositis. The level of awareness about familial Mediterranean fever is far from sufficient, and it is
assumed that there may be many patients with this disease who are under observation without an accurate
diagnosis.
Case presentation: A 30-year-old Japanese man presented to us with a few years’ history of recurrent episodes of
fever, abdominal pain and diarrhea. He often visited a hospital when the attacks occurred; however, acute enteritis was
diagnosed each time, and the symptoms resolved spontaneously within a few days. When he noticed a shortening of
the interval between the attacks, he visited the hospital again. Upper endoscopy and colonoscopy performed at this
hospital revealed no significant abnormal findings. He was then referred to our hospital under the suspicion of a small
intestinal disease. Abdominal computed tomography revealed wall thickening and increased density of the mesenteric
adipose tissue in the jejunum, which led us to suspect Crohn’s disease. Oral double-balloon enteroscopy was performed;
because this revealed only mild mucosal edema in the jejunum, Crohn’s disease was considered to be highly improbable.
Based on the patient’s clinical course, we suspected familial Mediterranean fever. As the Livneh criteria for familial
Mediterranean fever were satisfied, the patient was started on oral colchicine for the purpose of diagnostic treatment.
A definitive diagnosis of familial Mediterranean fever was then made based on the detection of a mutation of the
Mediterranean fever gene. A marked reduction in the frequency of attacks was observed in response to colchicine
treatment.
Conclusions: Although Crohn’s disease may be considered first in the differential diagnosis of young patients
presenting with periodic fever, abdominal pain and diarrhea, the possibility of familial Mediterranean fever
should also be borne in mind.
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Familial Mediterranean fever (FMF) is a hereditary peri-
odic syndrome with autosomal recessive inheritance that
is characterized by periodic fever and serositis, including
peritonitis and pleuritis. FMF was first reported in 1908
by Janeway and Mosenthal [1]. It is most frequently en-
countered among the hereditary periodic syndromes and
is estimated to affect 100,000 or more patients in the
world [2]. Abdominal pain and fever are the most frequent
clinical symptoms, which often makes definitive diagnosis
difficult. Herein, we report our experience of a case of FMF
in which a few years elapsed before a definitive diagnosis* Correspondence: s.w.himananon@ac.auone-net.jp
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article, unless otherwise stated.could be made, with the patient initially suspected as having
Crohn’s disease (CD).
Case presentation
A 30-year-old Japanese man presented with a few years’
history of recurrent episodes of fever, abdominal pain
and diarrhea that lasted for a few days and occurred a
few times a year. At the time of an attack, he experienced
abdominal pain spreading from the periumbilical area to
the entire abdomen, a few episodes of watery diarrhea per
day, and fever of approximately 38°C, all of which were
alleviated within a few days by fasting and resting. He
often visited a medical institution when the attacks
occurred; however, each time, he was diagnosed as hav-
ing acute enteritis. Between attacks, the patient wasntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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that the attacks had occurred once a month for
3 months in a row, he visited the medical institution
again. Upper and lower gastrointestinal endoscopy per-
formed at the institution did not reveal any significant
abnormal findings. The patient was then referred to
our hospital under the suspicion of a small intestinal
disease.
At the first visit, the patient presented with a fever of
approximately 38°C, abdominal pain, and a few episodes
of watery diarrhea per day. As the results of the blood
test at this visit, the findings of a white blood cell
(WBC) count of 8,060/μL (neutrophil [Neut]: 72.1%),
serum C-reactive protein (CRP) level of 14.64 mg/dL,
and erythrocyte sedimentation rate (ESR) of 39 mm/hr
suggested the presence of inflammation. He was admit-
ted for detailed examination and treatment 1 week later.
On admission, there was no fever, and the abdominal pain
and diarrhea had resolved. A repeat blood test revealed a
WBC count of 5,370/μL (Neut: 53.3%), serum CRP of
4.69 mg/dL, and ESR of 29 mm/hr, showing a trend to-
wards reduction of the inflammatory markers. Thyroid
function tests and serological tests for various autoanti-
bodies also revealed no abnormal findings.
As abdominal computed tomography (CT) revealed
wall thickening and increased density of the mesenteric
adipose tissue in the upper small intestine (Figure 1), we
suspected CD and performed oral double-balloon entero-
scopy (DBE). Although mild mucosal edema was detected
in the jejunum, neither erosions nor ulcers were observed
on the mucosal surface (Figure 2). A biopsy specimen
obtained from the edematous mucosa of the jejunum
revealed partial and slight inflammatory cell infiltration
and edematous changes. As a subsequently performed
transanal DBE revealed no abnormal findings, CD was
considered to be highly improbable.
We suspected FMF based on the clinical course and
evaluated the Livneh criteria for FMF (Table 1) [3].
Because the criteria were satisfied, oral administration
of colchicine was initiated at a daily dose of 0.5 mg.Figure 1 Findings of abdominal computed tomography (CT). A. showi
B. showing increased density of the mesenteric adipose tissue in the jejunuMolecular analysis for FMF was done by sequencing of
exon 1 and exons of 3–10 of familial Mediterranean
fever (MEFV) gene. The results of genetic analysis for
the MEFV gene demonstrated a heterozygous mutation
of M694I in exon 10. A definitive diagnosis of FMF
was then made. The patient did not have any family
history of the disease. Subsequently, although the attacks
were not completely eliminated, their frequency markedly
decreased. Only loose stools occurred for 2 to 3 days every
1 to 2 months, but there was no fever, abdominal pain, or
increases of the inflammatory markers in the blood test.
In order to achieve remission of the symptoms, an in-
crease in the dose of colchicine was considered. However,
because mild hepatic function impairment possibly caused
by colchicine was noted, the treatment has been main-
tained at the initial dose. Approximately 1 year has elapsed
since the initiation of the colchicine therapy, and the
disease state remains stable.
Discussion
FMF is a disease with a high prevalence rate in the
Mediterranean basin and is considered to be associated
with the highest morbidity among the hereditary periodic
syndromes [2]. In Japan, the first case of FMF was reported
by Hayashi et al. in 1976 [4]. An epidemiologic study con-
ducted in 2009 estimated the total number of patients with
the disease in Japan at 292 [5]. The level of awareness about
this disease is far from sufficient, and it is assumed that
there may be many patients with this disease who are under
observation without an accurate diagnosis.
Although the age at onset is considered to be less than
20 years in 90% of the cases, it is 19.6 ± 15.3 years in
Japan, which is higher than that reported from overseas.
Furthermore, it has been reported that in 37.3% of the
Japanese cases, the disease onset occurs at the age of
20 years or later [5]. Typically, an attack starts suddenly,
mainly with fever lasting for 1 to 4 days (6 to 96 hours),
and abdominal pain observed in 95% or more of the
cases. Diarrhea, which was observed in our patient, has
been reported to occur in 10% to 20% of the patients [2].ng a near-circumferential wall thickening in the jejunum (arrow).
m (arrow).
Figure 2 Findings of double-balloon enteroscopy (DBE). Oral DBE reveals mild mucosal edema in the upper segment of the jejunum.
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pain and diarrhea, small bowel CD was suspected at
first, because abdominal CT revealed thickening of the
upper small intestinal wall. Although blood tests revealed
an increase in the levels of inflammatory markers, there
was no weight loss, hypoalbuminemia, hypocholesterole-
mia, iron-deficiency anemia, etc. CD was definitively ruled
out by DBE. On the other hand, there are reports on
concurrent occurrence of FMF and CD [6-8], and also
the beneficial effect of colchicine for CD associated with
FMF [8].
The M694I mutation was the one most frequently
found in Japanese patients with FMF. The majority of
the patients were compound heterozygous or complex
allele for M694I mutations. The 17.5% of MEFV mutations
pattern were M694I alone [9]. FMF is basically an auto-
somal recessive disease; therefore, double mutations causeTable 1 Diagnostic criteria for familial Mediterranean
fever [3]
Major criteria: typical attack* Minor criteria
1. Peritonitis (generalized) 1. Incomplete attacks affecting
one or more sites
2. Pleurisy (unilateral) or pericarditis -Abdomen
3. Monoarthritis (hip, knee, ankle) -Lungs
4. Isolated fever -Joints
*axillary temperature >38°C, duration
12–72 h and ≥ three attacks
2. Exertion-related leg pain
3. Response to colchicine
The diagnosis requires at least one major criteria or at least two minor criteria.the disease. However, the genotype of some families
showed autosomal dominant inheritance of FMF [10].
Colchicine is considered to be the agent of first choice
for FMF, as it is highly effective [11-14]. Furthermore, it
can prevent the onset of amyloidosis, which is a compli-
cation that greatly affects the outcome, and can arrest
the progression of amyloidosis even after the onset. Col-
chicine is also effective for the prevention and treatment
of renal amyloidosis [11,15].
There are few reports on the endoscopic and patho-
logical findings of FMF. In our patient, because we found
a localized lesion on abdominal CT and determined that
detailed pathological examination would be required, DBE
was performed instead of double-contrast examination of
the small intestine. DBE only revealed mild edematous
change of the small intestinal mucosal surface. Because
FMF is primarily characterized by peritonitis, there may
be no abnormal findings or only mild abnormalities on
the mucosal surface.
Since the most common chief complaints are fever
and abdominal pain, the clinical presentation of FMF is
often difficult to differentiate from that of acute abdomen.
Thus, it is assumed that there may be patients with FMF
who unnecessarily undergo appendectomy or cholecyst-
ectomy. Because the features of Behcet’s disease also
sometimes satisfy the diagnostic criteria of FMF, careful
diagnosis is required [9]. It is expected that many pa-
tients with FMF visit outpatient gastrointestinal clinics.
In our patient, a few years had elapsed before a definitive
diagnosis could be made.
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Although our patient was initially suspected to have CD,
the disease was excluded by DBE. When patients with
periodic fever or peritonitis of unknown etiology are
encountered, FMF should be included in the differential
diagnosis. Dissemination of information about FMF to
gastroenterologists is also important.
Consent
Written informed consent was obtained from the patient
for publication of this Case Report and the accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
Ethical consideration
We obtained the patient’s agreement to the genetic
testing, but we didn’t receive ethics approval for the
genetic testing.
Abbreviations
FMF: Familial Mediterranean fever; CD: Crohn’s disease; WBC: White blood
cell; Neut: Neutrophil; CRP: C-reactive protein; ESR: Erythrocyte sedimentation
rate; CT: Computed tomography; DBE: Double-balloon enteroscopy.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
SM and SU made equal contributions to this paper. The two authors
diagnosed the patient, treated the patient. SM wrote a major part of the
manuscript. YY was involved in the editing of the manuscript. All authors
read and approved the final manuscript.
Acknowledgements
The authors have no support or funding to report.
Received: 27 March 2014 Accepted: 23 September 2014
Published: 27 September 2014
References
1. Janeway TC, Mosenthal HO: An unusual paroxysmal syndrome, probably
allied to recurrent vomiting, with a study of the nitorogen metabolism.
Trans Ass Am Phys 1908, 23:504–518.
2. Onen F: Familial Mediterranean fever. Rheumatol Int 2006, 26:489–496.
3. Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S,
Pras M: Criteria for the diagnosis of familial Mediterranean fever. Arthritis
Rheum 1997, 40:1879–1885.
4. Hayashi A, Suzuki T, Shimizu A, Yamamura Y: Letter: Periodic fever
suppressed by reserpine. Lancet 1976, 1:592.
5. Migita K, Agematsu K: Clinical aspects of Familial Mediterranean fever. Jpn
J Clin Immunol 2011, 34:355–360. in Japanese, Abstract in English.
6. Fidder HH, Chowers Y, Lidar M, Sternberg M, Langevitz P, Livneh A: Crohn
disease in patients with familial Mediterranean fever. Medicine 2002,
81:411–416.
7. Ghaffar TYA, Elsayed SM: Colchicine resistant FMF is not always true
resistance. Egypt J Med Hum Genet 2011, 12:99–101.
8. Kuloğlu Z, Kansu A, Ustündağ G, Birsin Özçakar Z, Ensari A, Ekim M: An
infant with severe refractory Crohn's disease and homozygous MEFV
mutation who dramatically responded to colchicine. Rheumatol Int 2012,
32:783–785.
9. Tsuchiya-Suzuki A, Yazaki M, Nakamura A, Yamazaki K, Agematsu K, Matsuda
M, Ikeda S: Clinical and genetic features of familial Mediterranean fever
in Japan. J Rheumatol 2009, 36:1671–1676.
10. Booth DR, Gillmore JD, Lachmann HJ, Booth SE, Bybee A, Soytürk M, Akar S,
Pepys MB, Tunca M, Hawkins PN: The genetic basis of autosomal
dominant familial Mediterranean fever. QJM 2000, 93:217–221.11. Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J: Colchicine in the
prevention and treatment of the amyloidosis of familial Mediterranean
fever. N Engl J Med 1986, 314:1001–1005.
12. Dinarello CA, Wolff SM, Goldfinger SE, Dale DC, Alling DW: Colchicine
therapy for familial mediterranean fever. A double-blind trial. N Engl J
Med 1974, 291:934–937.
13. Goldstein RC, Schwabe AD: Prophylactic colchicine therapy in familial
Mediterranean fever. A controlled, double-blind study. Ann Intern Med
1974, 81:792–794.
14. Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, Tutar E,
Ozen S, Topaloglu R, Yilmaz E, Arici M, Bakkaloglu A, Besbas N, Akpolat T,
Dinc A, Erken E, Turkish FMF Study Group: Familial Mediterranean fever
(FMF) in Turkey: results of a nationwide multicenter study. Medicine
(Baltimore) 2005, 84:1–11.
15. Ben-Chetrit E: Familial Mediterranean fever (FMF) and renal AA
amyloidosis-phenotype-genotype correlation, treatment and prognosis.
J Nephrol 2003, 16:431–434.
doi:10.1186/1756-0500-7-678
Cite this article as: Matsumoto et al.: Familial Mediterranean fever in
which Crohn’s disease was suspected: a case report. BMC Research Notes
2014 7:678.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
